Which oral antifungal is most commonly associated with drug‑induced esophageal ulcer (pill esophagitis)?

Drug-Induced Esophageal Ulcer from Antifungals

Among oral antifungal agents, tetracycline antibiotics (doxycycline, tetracycline) and clindamycin are the most common causes of pill-induced esophagitis, accounting for over 50% of cases, but among true systemic antifungals, no specific agent is prominently associated with direct caustic esophageal injury. 1

Understanding the Question Context

The question asks about antifungals causing esophageal ulcers through direct pill-induced injury (pill esophagitis), which is mechanistically distinct from infectious esophageal candidiasis:

Pill-Induced Esophagitis Mechanism

• Direct caustic mucosal injury occurs when tablets or capsules lodge in the esophagus and release their contents, causing local tissue damage 1
• Over 70 drugs have been reported to cause pill-induced esophagitis, with antibacterials (doxycycline, tetracycline, clindamycin) responsible for more than 50% of cases 1
• Other common offenders include NSAIDs, aspirin, potassium chloride, ferrous sulfate, quinidine, and alprenolol 1
• The typical presentation includes odynophagia, retrosternal chest pain, and dysphagia, with discrete mid-esophageal ulcers on endoscopy 2

Antifungal Agents and Esophageal Injury

• Systemic azole antifungals (fluconazole, itraconazole, voriconazole, posaconazole) are not prominently listed among the common causes of pill-induced esophagitis in the comprehensive drug safety literature 1, 3
• The evidence base focuses on these agents as treatments for infectious esophageal candidiasis rather than causes of direct esophageal injury 4, 5
• Ketoconazole has historical use for esophageal candidiasis treatment but is not highlighted as a caustic agent 6

Risk Factors for Pill-Induced Esophagitis (Any Medication)

• Taking medications at bedtime or without adequate fluids (≥200 mL water recommended) 1, 3
• Supine posture immediately after ingestion 3
• Large tablets or gelatin-coated capsules 3
• Underlying esophageal motility disorders, strictures, or extrinsic compression 3
• Delayed esophageal transit time 1

Clinical Approach When Suspected

Diagnosis

• History of recent medication initiation with acute onset of odynophagia, retrosternal pain, or dysphagia 2, 3
• Endoscopy reveals discrete ulcers, typically in the mid-esophagus, with a "kissing ulcer" appearance possible 2, 7
• Biopsy shows inflamed granulation tissue without infection or malignancy 7

Management

• Immediate discontinuation of the suspected causative drug 2, 3
• Supportive care with acid suppression therapy as adjunct 1
• Most patients recover uneventfully with conservative management 2
• Endoscopy is reserved for severe or atypical symptoms 3

Prevention Strategies

• Instruct patients to take oral medications with at least 200 mL of water 3
• Avoid taking pills immediately before lying down; remain upright for 30 minutes after ingestion 1, 3
• Consider liquid formulations when available for high-risk patients 3
• Review medication formulation (avoid large or gelatin-coated tablets in at-risk patients) 3

Key Clinical Distinction

It is critical to distinguish pill-induced esophageal ulcers from infectious esophageal candidiasis, as the latter requires systemic antifungal therapy while the former requires drug cessation 8. Infectious esophageal candidiasis presents with white mucosal plaques that cannot be washed off with irrigation, occurs primarily in immunocompromised hosts, and is confirmed by biopsy showing yeast and pseudohyphae invading mucosal cells 8.